---
title: Prediction of pathological complete response after neoadjuvant chemotherapy
  for HER2-negative breast cancer patients with routine immunohistochemical markers
date: '2025-01-25'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39856787/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250125170422&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: A pCR prediction model for neoadjuvant therapy decision-making
  was established. Combining pCR and recurrence prediction allows identification of
  not only patients who benefit most from neoadjuvant chemotherapy, but also patients
  with a very unfavorable prognosis for whom alternative treatment strategies should
  be ...'
disable_comments: true
---
CONCLUSIONS: A pCR prediction model for neoadjuvant therapy decision-making was established. Combining pCR and recurrence prediction allows identification of not only patients who benefit most from neoadjuvant chemotherapy, but also patients with a very unfavorable prognosis for whom alternative treatment strategies should be ...